Madura J Rangaraj

Statistics

Publications

Citations

361

H-Index

Active since

2013

Affiliations

Diabetes Australia(Current)

Universidade Federal de São Paulo

Cabrini Medical Center

Cabrini Hospital

Humboldt-Universität zu Berlin

Madura J Rangaraj is an author at Diabetes Australia specializing in inflammatory disease pharmacotherapy, disease-modifying anti-inflammatory drugs, and rheumatoid arthritis therapy.

Publications per year

2013–2015

Publications

A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)

Gerd R Burmester, Andrea Rubbert‐Roth, Alain Cantagrel et al. · Annals of the Rheumatic Diseases · 2013 · 238 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)

Gerd R Burmester, Andrea Rubbert‐Roth, Alain Cantagrel et al. · Annals of the Rheumatic Diseases · 2015 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

1–2 of 2